Login / Signup
Torsten Trowe
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 6
Top Topics
High Glucose
Tyrosine Kinase
Endothelial Cells
Drug Administration
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
Clinical and translational science
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Anthony W Tolcher
,
Joshua D Brody
,
Nishanthan Rajakumaraswamy
,
Michelle R Kuhne
,
Torsten Trowe
,
Anees M Dauki
,
Shantheri Pai
,
Ling Han
,
Kai-Wen Lin
,
Michael Petrarca
,
Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (14) (2024)
Anthony W Tolcher
,
Joshua D Brody
,
Nishanthan Rajakumaraswamy
,
Michelle R Kuhne
,
Torsten Trowe
,
Anees M Dauki
,
Shantheri Pai
,
Ling Han
,
Kai-Wen Lin
,
Michael Petrarca
,
Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (14) (2024)
Anthony W Tolcher
,
Joshua D Brody
,
Nishanthan Rajakumaraswamy
,
Michelle R Kuhne
,
Torsten Trowe
,
Anees M Dauki
,
Shantheri Pai
,
Ling Han
,
Kai-Wen Lin
,
Michael Petrarca
,
Shivaani Kummar
Phase I Study of GS-3583, a FLT3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Anthony W Tolcher
,
Joshua D Brody
,
Nishanthan Rajakumaraswamy
,
Michelle R Kuhne
,
Torsten Trowe
,
Anees M Dauki
,
Shantheri Pai
,
Ling Han
,
Kai-Wen Lin
,
Michael Petrarca
,
Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (14) (2024)
Anees M Dauki
,
Nishanthan Rajakumaraswamy
,
Torsten Trowe
,
Winnie Weng
,
Kai-Wen Lin
,
Emon Elboudwarej
,
Ann Ran-Ran Qin
,
Christian Schwabe
,
Michelle R Kuhne
,
Ahmed A Othman
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants.
Clinical and translational science
17 (8) (2024)
Anees M Dauki
,
Nishanthan Rajakumaraswamy
,
Torsten Trowe
,
Winnie Weng
,
Kai-Wen Lin
,
Emon Elboudwarej
,
Ann Ran-Ran Qin
,
Christian Schwabe
,
Michelle R Kuhne
,
Ahmed A Othman
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants.
Clinical and translational science
17 (8) (2024)